Ticker Report Bank of New York Mellon Corp boosted its stake in shares of Vertex, Inc. (NASDAQ:VERX - Free Report) by 545.4% during the 2nd quarter, according to the company in its most recent filing with the...\n more…
Zacks Investment Research Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $470.78, moving -0.07% from the previous trading session. The stock's change was less than the S&P 500's daily gain of 0.45...\n more…
Ticker Report Principal Financial Group Inc. lowered its holdings in Vertex, Inc. (NASDAQ:VERX - Free Report) by 43.4% during the second quarter, according to the company in its most recent Form 13F filing with...\n more…
Ticker Report Vertex, Inc. (NASDAQ:VERX - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the twelve analysts that are covering the company, MarketBeat reports. Four equities...\n more…
Ticker Report Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in Vertex, Inc. (NASDAQ:VERX - Free Report) by 13.3% during the second quarter, HoldingsChannel.com reports. The institutional investor...\n more…